The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study

Author:

Chua Kyra Y L1,Vogrin Sara2,Bury Susan13,Douglas Abby4,Holmes Natasha E1,Tan Nixon1,Brusco Natasha K56,Hall Rebecca1,Lambros Belinda4,Lean Jacinta4,Stevenson Wendy1,Devchand Misha13,Garrett Kent3,Thursky Karin478,Grayson M Lindsay19,Slavin Monica A48,Phillips Elizabeth J1011,Trubiano Jason A149

Affiliation:

1. Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Australia

2. Department of Medicine, St Vincent’s Hospital, University of Melbourne, Fitzroy, Australia

3. Department of Pharmacy, Austin Health, Heidelberg, Australia

4. Department of Infectious Diseases and the National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia

5. Alpha Crucis Group, Health Economics, Langwarrin, Australia

6. Rehabilitation, Ageing and Independent Living Research Centre, Monash University, Frankston, Australia

7. National Centre for Antimicrobial Stewardship, Royal Melbourne Hospital, Melbourne, Australia

8. Department of Oncology, Sir Peter MacCallum Cancer Centre, University of Melbourne, Parkville, Australia

9. Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Australia

10. Department of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA

11. Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia

Abstract

Abstract Background Penicillin allergies are associated with inferior patient and antimicrobial stewardship outcomes. We implemented a whole-of-hospital program to assess the efficacy of inpatient delabeling for low-risk penicillin allergies in hospitalized inpatients. Methods Patients ≥ 18 years of age with a low-risk penicillin allergy were offered a single-dose oral penicillin challenge or direct label removal based on history (direct delabeling). The primary endpoint was the proportion of patients delabeled. Key secondary endpoints were antibiotic utilization pre- (index admission) and post-delabeling (index admission and 90 days). Results Between 21 January 2019 and 31 August 2019, we assessed 1791 patients reporting 2315 antibiotic allergies, 1225 with a penicillin allergy. Three hundred fifty-five patients were delabeled: 161 by direct delabeling and 194 via oral penicillin challenge. Ninety-seven percent (194/200) of patients were negative upon oral penicillin challenge. In the delabeled patients, we observed an increase in narrow-spectrum penicillin usage (adjusted odds ratio [OR], 10.51 [95% confidence interval {CI}, 5.39–20.48]), improved appropriate antibiotic prescribing (adjusted OR, 2.13 [95% CI, 1.45–3.13]), and a reduction in restricted antibiotic usage (adjusted OR, 0.38 [95% CI, .27–.54]). In the propensity score analysis, there was an increase in narrow-spectrum penicillins (OR, 10.89 [95% CI, 5.09–23.31]) and β-lactam/β-lactamase inhibitors (OR, 6.68 [95% CI, 3.94–11.35]) and a reduction in restricted antibiotic use (OR, 0.52 [95% CI, .36–.74]) and inappropriate prescriptions (relative risk ratio, 0.43 [95% CI, .26–.72]) in the delabeled group compared with the group who retained their allergy label. Conclusions This health services program using a combination of direct delabeling and oral penicillin challenge resulted in significant impacts on the use of preferred antibiotics and appropriate prescribing.

Funder

Department of Health, State Government of Victoria

National Health and Medical Research Council

Royal Australasian College of Physicians

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3